CT scans predict chemo penetration and effectiveness in new study; Oramed wins oral diabetes treatment patent in Australia;

> In a new study from the University of Texas, CT scans have shown to be effective at reflecting how well chemotherapy will penetrate a pancreatic tumor and predicting how well a treatment would work. More

> Oramed won its third patent in Australia for the oral administration of exenatide, a diabetes treatment. Release

> Orexo teamed up with UnitedHealth Group and OptumRx for coverage and reimbursement of its sublingual opioid dependence treatment, Zubzolv. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.